SUNNYVALE, Calif.--(BUSINESS WIRE)--Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today that it will showcase demonstration of the next-generation 120µm thin-strut bioresorbable scaffold system, DESolve CX at EuroPCR in Paris. EuroPCR is the annual meeting of the European Association for Percutaneous Cardiovascular Interventions.